63 results
Page 2 of 4
8-K
58sfc5ckjiuhdl
3 Feb 21
Other Events
5:25pm
424B5
u0v04 7gr7
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
h86guj
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
l10wut48vkq494
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
or7qjvz7h73jr2 t3lj
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
424B3
4ymp7x4e7gej
28 Aug 20
Prospectus supplement
4:31pm
425
5z41v
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.4
zgndgbibquvw9
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
c90qins zssn4twz
6 Aug 19
Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume
4:17pm